Literature DB >> 12853513

Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment.

Forest W Arnold1, Julio A Ramirez, L Clifford McDonald, Eric L Xia.   

Abstract

STUDY
OBJECTIVES: (1) To define clinical factors that could justify hospital admission among patients with community-acquired pneumonia (CAP) with risk classes of I or II. (2) To determine the positive predictive value of the pneumonia severity index as the sole indicator for detecting inappropriate hospitalizations among patients with CAP.
DESIGN: Retrospective observational study.
SETTING: University of Louisville Hospital and the Veterans Affairs Medical Center of Louisville, KY. PATIENTS: Consecutive adult patients fulfilling the criteria for CAP who were admitted to the hospital between October 1997 and May 2000. MEASUREMENTS AND
RESULTS: The medical records of hospitalized patients with CAP having a risk class of I or II were identified and further reviewed to determine whether there existed a clinical basis to justify hospitalization. Of a total of 328 patients, 86 had a risk class of I or II. Among these, 72 had clinical factors that justified their hospital admission. These factors, in frequency of occurrence, included the following: medical conditions other than CAP that required hospitalization, 31 patients (43%); social needs, 13 patients (18%); oral intolerance, 10 patients (14%); failure of outpatient therapy, 10 patients (14%); noncompliance, 6 patients (9%); suspicion of sepsis, 1 patient (1%); and hypoxemia, 1 patient (1%). Among the 86 patients with low risk classes (ie, classes I or II), 14 were found to be inappropriately hospitalized, yielding a positive predictive value of 16%.
CONCLUSIONS: The pneumonia severity index, used as the sole indicator for detecting inappropriate hospitalizations, has an unacceptably low positive predictive value. This is due primarily to the severity of comorbid conditions requiring in-hospital care in patients with a nonsevere pneumonia. According to our study, the pneumonia severity index should not be used as the sole indicator with which to define inappropriate hospitalization.

Entities:  

Mesh:

Year:  2003        PMID: 12853513     DOI: 10.1378/chest.124.1.121

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes.

Authors:  Michael J Lanspa; Paula Peyrani; Timothy Wiemken; Emily L Wilson; Julio A Ramirez; Nathan C Dean
Journal:  J Hosp Med       Date:  2014-11-01       Impact factor: 2.960

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Authors:  Jose Labarere; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Thomas E Auble; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

5.  A randomized, open, multicenter clinical study on the short course of intravenous infusion of 750 mg of levofloxacin and the sequential standard course of intravenous infusion/oral administration of 500 mg of levofloxacin for treatment of community-acquired pneumonia.

Authors:  Tiemei Zhao; Liang-An Chen; Ping Wang; Guizhen Tian; Feng Ye; Huili Zhu; Bei He; Baiying Zhang; Changzhou Shao; Zhijun Jie; Xiwen Gao; Dongxia Wang; Weidong Song; Zhijie Pan; Jin Chen; Xingyi Zhang; Zhancheng Gao; Ping Chen; Youning Liu
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.

Authors:  T C Jenkins; S A Stella; L Cervantes; B C Knepper; A L Sabel; C S Price; L Shockley; M E Hanley; P S Mehler; W J Burman
Journal:  Infection       Date:  2012-11-17       Impact factor: 3.553

7.  Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.

Authors:  J M Bordon; R Fernandez-Botran; T L Wiemken; P Peyrani; S M Uriarte; F W Arnold; L Rodriquez-Hernandez; M J Rane; R R Kelley; L E Binford; S Uppatla; R Cavallazzi; F Blasi; S Aliberti; M I Restrepo; S Fazeli; A Mathur; M Rahmani; K Ayesu; J Ramirez
Journal:  Infection       Date:  2015-09-30       Impact factor: 3.553

Review 8.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  The value of prognostic indices for pneumonia.

Authors:  Jennie Johnstone; Sumit R Majumdar; Thomas J Marrie
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.